Sommario

• • ·Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome

    Pagina :1020-1027

    Andrew T. Yan, Philip Jong, Raymond T. Yan, Mary Tan, David Fitchett, Chi-Ming Chow, Matthew T. Roe, Karen S. Pieper, Anatoly Langer, Shaun G. Goodman, for the Canadian Acute Coronary Syndromes (ACS) Registry Investigators a b c

    Riassunto Riassunto Mappa Mappa  
• • ·Pulsed wave tissue Doppler-derived myocardial performance index for the assessment of left ventricular thrombus formation risk after acute myocardial infarction

    Pagina :1102-1108

    Remzi Yilmaz, Sukru Celik, Merih Baykan, Cihan Orem, Hasan Kasap, Ismet Durmus, Cevdet Erdol

    Riassunto Riassunto Mappa Mappa  
• • ·Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: The 30-day outcome associated with normal left ventricular wall motion

    Pagina :1096-1101

    Patrick Weston, John H. Alexander, Manesh R. Patel, Charles Maynard, Lawrence Crawford, Galen S. Wagner

    Riassunto Riassunto Mappa Mappa  
• • ·Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure

    Pagina :964-970

    Kunihiro Yamada, Hidetsugu Asanoi, Hiroshi Ueno, Shuji Joho, Junya Takagawa, Tomoki Kameyama, Tadakazu Hirai, Takashi Nozawa, Hiroshi Inoue

    Riassunto Riassunto Mappa Mappa  
• • ·The continuing importance of prior stroke in STEMI patients

    Pagina :931-936

    Michael A. Sloan

    
• • ·Direct Stenting Compared to Conventional Stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): A multicenter, open label, randomized, controlled efficacy study

    Pagina :1007-1011

    Huay Cheem Tan, Yean Teng Lim, Tuan L.A. Rosli, Kui Hian Sim, Kim Heung Tan, Chi Hang Lee, Omar Ismail, Wan Azman

    Riassunto Riassunto Mappa Mappa
• • ·Peer group benchmarks are not appropriate for health care quality report cards

    Pagina :921-923

    Patrick S. Romano

    
• • ·GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention

    Pagina :1003-1006

    Jose E. Exaire, Sorin J. Brener, Stephen G. Ellis, Jay S. Yadav, Deepak L. Bhatt

    Riassunto Riassunto Mappa Mappa
• • ·Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial

    Pagina :1012-1019

    Howard A. Cooper, Michael J. Domanski, Yves Rosenberg, James Norman, Judith H. Scott, Susan F. Assmann, Sonja M. McKinlay, Judith S. Hochman, Elliott M. Antman, the MAGIC Trial Investigators

    Riassunto Riassunto Mappa Mappa  
• • ·Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials

    Pagina :990-997

    Mark D. Schleinitz, Ingram Olkin, Paul A. Heidenreich

    Riassunto Riassunto Mappa Mappa  
• • ·Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction

    Pagina :1068-1078

    Salim Yusuf, Shamir R. Mehta, Rafael Díaz, Ernesto Paolasso, Prem Pais, Denis Xavier, Changchun Xie, Rashid J. Ahmed, Khawar Khazmi, Jun Zhu, Lisheng Liu, CREATE-ECLA Investigators and Steering Committee

    Riassunto Riassunto Mappa Mappa  
• • ·Table of contents

    Pagina :A1

    
• • ·Editorial board

    Pagina :A5

    
• • ·Information for authors

    Pagina :A6

    
• • ·Information for readers

    Pagina :A8

    
• • ·Change of address

    Pagina :923

     
• • ·Glucose-insulin-potassium therapy for acute myocardial infarction: What goes around comes around

    Pagina :924-930

    Charlie I. Gnaim, Darren K. McGuire

    Mappa Mappa  
• • ·Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized, controlled trials

    Pagina :937-943

    João Otávio de Queiroz Fernandes Araújo, Henrique Horta Veloso, Joyce Morgana Braga De Paiva, Mohamed Wafae Filho, Angelo Amato Vincenzo De Paola

    Riassunto Riassunto Mappa Mappa  
• • ·Benefits of inpatient initiation of β-blockers

    Pagina :944-950

    Hector O. Ventura

    Riassunto Riassunto Mappa Mappa  
• • ·Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)

    Pagina :951-957

    Lawrence Baruch, Robert D. Glazer, Nora Aknay, Johan Vanhaecke, J. Thomas Heywood, Inder Anand, Henry Krum, Allen Hester, Jay N. Cohn

    Riassunto Riassunto Mappa Mappa  
• • ·β-blocker therapy in patients with heart failure in the urban setting: Moving beyond clinical trials

    Pagina :958-963

    Jerry D. Estep, Sameer K. Mehta, Fatema Uddin, Louise King, Kathleen H. Toto, Lauren L. Nelson, Daniel L. Dries, Clyde W. Yancy, Mark H. Drazner

    Riassunto Riassunto Mappa Mappa  
• • ·Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

    Pagina :971-978

    Kamala P. Tamirisa, Keith D. Aaronson, Todd M. Koelling

    Riassunto Riassunto Mappa Mappa  
• • ·Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: The Jackson Cohort of the Atherosclerotic Risk in Communities Study

    Pagina :979-984

    Ervin Fox, Doug Harkins, Herman Taylor, Michael McMullan, Hui Han, Tandaw Samdarshi, Robert Garrison, Thomas Skelton

    Riassunto Riassunto Mappa Mappa  
• • ·Autonomic profile and arrhythmic risk stratification after surgical repair of tetralogy of Fallot

    Pagina :985-989

    Antonio Franco Folino, Giulia Russo, Barbara Bauce, Elisa Mazzotti, Luciano Daliento

    Riassunto Riassunto Mappa Mappa
• • ·Impact of female sex on outcome after percutaneous coronary intervention

    Pagina :998-1002

    John H. Chiu, Deepak L. Bhatt, Khaled M. Ziada, Derek P. Chew, Patrick L. Whitlow, A. Michael Lincoff, Stephen G. Ellis, Eric J. Topol

    Riassunto Riassunto Mappa Mappa  
• • ·Loratidine improves ischemic parameters of exercise stress test in patients with acute myocardial infarction

    Pagina :1019-1023

    Okan Erdogan, Armagan Altun, Sabri Gazi, Gultac Ozbay

    Riassunto Riassunto Mappa Mappa  
• • ·How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry

    Pagina :1028-1033

    Daniel G. Hackam, Mary K.K. Tan, George N. Honos, Lawrence A. Leiter, Anatoly Langer, Shaun G. Goodman, Vascular Protection (VP) Registry Investigators

    Riassunto Riassunto Mappa Mappa  
• • ·Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes

    Pagina :1034-1040

    Matthew J. Kolek, John F. Carlquist, Joseph B. Muhlestein, Bryant M. Whiting, Benjamin D. Horne, Tami L. Bair, Jeffrey L. Anderson

    Riassunto Riassunto Mappa Mappa
• • ·Impact of the choice of benchmark on the conclusions of hospital report cards

    Pagina :1041-1046

    Peter C. Austin, David A. Alter, Geoffrey M. Anderson, Jack V. Tu

    Riassunto Riassunto Mappa Mappa  
• • ·Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study

    Pagina :1047-1052

    Olaf Schouten, Don Poldermans, Loes Visser, Miklos D. Kertai, Jan Klein, Hero van Urk, Maarten L. Simoons, Louis L. van de Ven, Maarten Vermeulen, Jeroen J. Bax, Thomas W. Lameris, Eric Boersma

    Mappa Mappa  
• • ·Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: The rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE)

    Pagina :1053-1059

    Prakash C. Deedwania, SAGE Steering Committee and Investigators

    Riassunto Riassunto Mappa Mappa  
• • ·Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: Design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study

    Pagina :1060-1067

    Stefan N. Willich, Jacqueline Müller-Nordhorn, Frank Sonntag, Heinz Völler, Wolfgang Meyer-Sabellek, Karl Wegscheider, Eberhard Windler, Hugo Katus

    Riassunto Riassunto Mappa Mappa  
• • ·Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy

    Pagina :1079-1084

    Manolis Bountioukos, Arend F.L. Schinkel, Jeroen J. Bax, Elena Biagini, Vittoria Rizzello, Boudewijn J. Krenning, Eleni C. Vourvouri, Jos R.T.C. Roelandt, Don Poldermans

    Riassunto Riassunto Mappa Mappa  
• • ·Methodology for improved detection of coronary stenoses with computed tomographic angiography

    Pagina :1085-1090

    Matthew J. Budoff, Bin Lu, Jerold S. Shinbane, Lynn Chen, Janis Child, Sivi Carson, SongShou Mao

    Riassunto Riassunto Mappa Mappa  
• • ·Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: An echocardiographic-surgical correlative study

    Pagina :1091-1095

    Tsung O. Cheng, Ming-Xing Xie, Xin-Fang Wang, Ying Wang, Qing Lu

    Riassunto Riassunto Mappa Mappa  
• • ·Author index

    Pagina :1109-1123

    
• • ·Subject index

    Pagina :1124-1140

    
• • ·Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

    Pagina :e1

    J.M. Alvarez

    
• • ·Reply

    Pagina :e2

    Mohamed Y. Rady, Daniel J. Johnson

    
• • ·Letter to the editor

    Pagina :e3

    Jeffrey A. Johnson, Sumit R. Majumdar

    
• • ·Reply

    Pagina :e4

    Darren K. McGuire, L.Kristin Newby

    
• • ·Letter to the editor

    Pagina :e5

    Steven G. Coca, Gregory K. Buller

    
• • ·Reply

    Pagina :e6

    Kenji Okumura, Junichiro Kondo, Toyoaki Murohara, Kenji Okumura, Junichiro Kondo, Toyoaki Murohara

    
• • ·The potential benefits of trimetazidine in patients with diabetes and ischemic cardiomyopathy

    Pagina :e7

    Panagiotis Korantzopoulos, Evaggelos Kountouris, Konstantinos Siogas, Dimitrios Galaris

    
• • ·Reply

    Pagina :e8

    Gabriele Fragasso, Altin Palloshi, Alberto Margonato

    
• • ·Cardiac abnormalities in myotonic dystrophy type 1

    Pagina :e9

    Josef Finsterer, Claudia Stöllberger

    
• • ·The prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I

    Pagina :e10

    Deepak Bhakta, Miriam R. Lowe, William J. Groh